A RS is often a sign of a company in peril; yes, the share structure might seem more appealing, but in the public eye it typically results in "scared selling".
I think Tauriga is, for the most part, making the right decisions. FOR THE MOST PART.
I trust this management, but like everyone here will agree on, we won't see any real progress in share price until solid PILUS updates come out. I like the idea of the supplement line, but it's not why I'm here.